Studies have shown that the use of anticoagulants such as tissue factor pathway inhibitor, antithrombin, heparin, activated protein C and plasmin activator, especially tissue type plasmin activator, can significantly improve lung function and increase oxygen supply in ALI and ARDS (109, 110). This evidence concerns the gene F3 and acute respiratory distress syndrome.